Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

PK1 to enter phase II

March 15, 1996

MEN-10746 selected for development

March 15, 1996

MEN-10755 named as candidate for clinical study

March 15, 1996

Inex reports on liposomal vincristine development

March 15, 1996

Kirin anticancer drug in clinical trials

March 15, 1996

Aminopterin resurrected for ALL

March 15, 1996

University of Bradford reports on cytotoxic indoloquinone

March 15, 1996

Distamycin analogue from P&U shows cytotoxic effects

March 15, 1996

MGI-114 enters phase I

March 15, 1996

Andrulis' platinum-polymer complex

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...